VOQP
Price:
$0.003
Market Cap:
$14.72K
VioQuest Pharmaceuticals, Inc. is a biopharmaceutical entity that concentrates on obtaining, developing, and marketing drug therapies in clinical stages, specifically targeting oncology and infectious diseases. Its primary product, Xyfid, is currently being advanced for both the management and prevention of hand-foot syndrome. The company's pipeline also features VQD-002, a nucleoside analog presently in Phase I clinical trials for cancer treatment. Another key compound is Lenocta, a small molecule designed to inhibit various protein tyrosine phosphatases, which is progressing through Phase IIa clinical studies for indications like melanoma, renal cell carcinoma, and other solid tumors. Beyo...[Read more]
Industry
Biotechnology
IPO Date
1994-04-04
Stock Exchange
OTC
Ticker
VOQP
According to VioQuest Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -98.22% compared to the average of -0.56 of the last 4 quarters.
The mean historical PE Ratio of VioQuest Pharmaceuticals, Inc. over the last ten years is -0.20. The current -0.01 PE Ratio has changed 409.54% with respect to the historical average. Over the past ten years (40 quarters), VOQP's PE Ratio was at its highest in in the March 2002 quarter at 11.67. The PE Ratio was at its lowest in in the September 2002 quarter at -329.74.
Average
-0.20
Median
-1.89
Minimum
-90.36
Maximum
79.42
Discovering the peaks and valleys of VioQuest Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 7.91%
Maximum Annual PE Ratio = 79.42
Minimum Annual Increase = -2078.69%
Minimum Annual PE Ratio = -90.36
| Year | PE Ratio | Change |
|---|---|---|
| 2007 | -0.43 | -82.85% |
| 2006 | -2.50 | 94.27% |
| 2005 | -1.29 | -62.13% |
| 2004 | -3.40 | -65.62% |
| 2003 | -9.89 | -89.05% |
| 2002 | -90.36 | 7.91% |
| 2001 | -1.13 | -85.30% |
| 2000 | -7.67 | -121.75% |
| 1999 | 35.28 | -55.57% |
| 1998 | 79.42 | -2078.69% |
The current PE Ratio of VioQuest Pharmaceuticals, Inc. (VOQP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.41
5-year avg
-3.50
10-year avg
-0.20
VioQuest Pharmaceuticals, Inc.’s PE Ratio is greater than Regenicin, Inc. (-0.02), less than Q BioMed Inc. (-0.00), less than Poniard Pharmaceuticals, Inc. (-0.00), less than Scopus BioPharma Inc. (-0.00), less than Aeolus Pharmaceuticals, Inc. (-0.00), less than RenovaCare, Inc. (-0.00), greater than Strategic Partners A/S (-28.16), greater than Vaxxinity, Inc. (-0.22), less than PaxMedica, Inc. Common Stock (-0.00), less than NanoLogix, Inc. (-0.01),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.02 | $15.35K | |
| -0.00 | $14.51K | |
| -0.00 | $150.00 | |
| -0.00 | $16.83K | |
| -0.00 | $15.21K | |
| -0.00 | $8.73K | |
| -28.16 | $3.72M | |
| -0.22 | $12.68K | |
| -0.00 | $88.39K | |
| -0.01 | $11.96K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VioQuest Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VioQuest Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is VioQuest Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for VioQuest Pharmaceuticals, Inc. (VOQP)?
What is the highest PE Ratio for VioQuest Pharmaceuticals, Inc. (VOQP)?
What is the 3-year average PE Ratio for VioQuest Pharmaceuticals, Inc. (VOQP)?
What is the 5-year average PE Ratio for VioQuest Pharmaceuticals, Inc. (VOQP)?
How does the current PE Ratio for VioQuest Pharmaceuticals, Inc. (VOQP) compare to its historical average?